Joint Pain and Menopause: The Oestrogen Connection You Didn't Know About

Joint Pain and Menopause: The Oestrogen Connection You Didn't Know About

You wake up and your fingers feel like they've been glued shut overnight. Your knees creak on the stairs. Your hips ache after a walk that would have felt easy two years ago. You're in your mid-to-late forties, and everyone — including sometimes your doctor — tells you it's just part of getting older.

It isn't. Or at least, that's not the whole story.

For many women in perimenopause and menopause, joint pain is directly connected to falling oestrogen levels. It's one of the most underreported symptoms of the menopause transition, and one of the most disruptive to daily life. Understanding the mechanism is the first step toward doing something about it.

What the Numbers Actually Tell Us

Joint pain in menopause is far more common than most women realise. A 2011 study published in Menopause: The Journal of The Menopause Society found that musculoskeletal symptoms — including joint pain and stiffness — were reported by approximately half of all women during the menopausal transition, making it one of the most prevalent complaints alongside vasomotor symptoms like hot flushes.¹

A 2019 analysis in Maturitas noted that articular pain — pain originating in the joints — was significantly associated with lower oestrogen levels and that the onset frequently coincided with the perimenopause window, often years before the final menstrual period.²

Yet because joint pain is also associated with ageing in general, women are routinely told to expect it and manage it with over-the-counter anti-inflammatories. The hormonal driver is frequently left unaddressed.

Why Oestrogen Matters to Your Joints

Oestrogen (specifically oestradiol, the primary form in reproductive-age women) does far more than regulate your menstrual cycle. It plays a significant role in maintaining the structural health of connective tissue throughout the body — including cartilage, tendons, ligaments, and synovial membranes (the tissue lining your joints).

Here's what the research shows about oestrogen's role in joint health:

1. It modulates inflammation.
Oestrogen has anti-inflammatory properties. It influences the production of cytokines — signalling proteins that regulate inflammation — including interleukin-1 (IL-1) and tumour necrosis factor-alpha (TNF-α). When oestrogen declines, the inflammatory balance can tip, leading to increased joint inflammation and pain.³

2. It supports cartilage integrity.
Chondrocytes — the cells that maintain cartilage — carry oestrogen receptors. Studies have shown that oestrogen helps regulate chondrocyte metabolism, supporting cartilage production and inhibiting degradation. Lower oestrogen means reduced support for the tissue that cushions your joints.⁴

3. It affects collagen production.
Oestrogen stimulates collagen synthesis. Collagen is the primary structural protein in tendons, ligaments, and the synovial membrane. As oestrogen falls, collagen production declines — leading to joint laxity, reduced shock absorption, and increased susceptibility to pain and injury.⁵

4. It influences pain perception.
Oestrogen receptors are found in pain-processing regions of the central nervous system. Research suggests oestrogen may play a role in modulating pain sensitivity, meaning lower levels can increase how intensely pain signals are perceived — even before structural damage occurs.⁶

Where Does the Pain Show Up?

Menopause-related joint pain can manifest almost anywhere, but certain joints are more commonly affected:

• Hands and fingers — often presenting as morning stiffness and aching, sometimes mistaken for early rheumatoid arthritis
• Knees — one of the most reported sites; cartilage loss accelerates after menopause
• Hips — pain that can affect walking, sleep position, and daily mobility
• Spine (neck and lower back) — disc degeneration is influenced by oestrogen, and many women notice new or worsening back pain in perimenopause
• Jaw (TMJ) — less commonly discussed but documented; temporomandibular joint dysfunction has been linked to hormonal fluctuation

The pattern is often bilateral (affecting both sides), which can help distinguish it from injury-related pain that typically affects one side.

Perimenopause vs. Menopause: When Does It Start?

A critical point that is frequently missed: joint pain often begins in perimenopause, not after periods have stopped. Perimenopause can begin in the early-to-mid forties (sometimes earlier), and oestrogen levels during this phase are highly erratic — swinging both high and low.

These fluctuations, rather than simple low oestrogen, appear to be particularly disruptive to joint tissue. A 2016 study in Arthritis & Rheumatology found that women in the perimenopause transition had significantly higher rates of new joint pain than pre-menopausal women of similar age, supporting the role of hormonal volatility rather than simply low hormone levels.⁷

This means women in their early to mid-forties who are experiencing unexpected joint pain should consider hormonal status as a possible contributing factor — even if their periods are still regular.

How Is This Different From Arthritis?

This is a question many women ask — and it's a reasonable one, because the symptoms can overlap. Key distinguishing features of menopausal joint pain:

• Onset correlates with hormonal change — the pain emerged or worsened around the perimenopause/menopause transition
• Symmetrical distribution — both knees, both hands, both hips
• Morning stiffness that improves — often better after moving around, unlike inflammatory arthritis which may persist
• No joint swelling or redness (typically) — structural deformity is not a feature of hormonal joint pain in the early stages
• Associated symptoms — if you also have hot flushes, sleep disruption, mood changes, brain fog, or changes in your cycle, the picture becomes clearer

That said, menopause does not exclude arthritis. Oestrogen decline is also a risk factor for the development of osteoarthritis, particularly in the knees. If you're experiencing significant, persistent, or worsening joint symptoms, a clinical assessment — including bloodwork — is essential.

What Are the Evidence-Based Options?

Hormone Replacement Therapy (HRT)
The most direct intervention for oestrogen-driven joint pain is addressing the hormonal cause. Multiple studies have found that HRT — particularly oestrogen-containing regimens — is associated with reduced joint pain and lower rates of osteoarthritis progression. A large observational study published in Annals of the Rheumatic Diseases found that postmenopausal women on HRT had significantly lower risk of knee osteoarthritis.⁸ HRT is a medical treatment that requires consultation with a qualified healthcare provider; suitability varies by individual history.

Exercise and strength training
Resistance training helps maintain muscle mass around joints, reducing load on cartilage. Low-impact exercise (swimming, cycling, walking) supports joint mobility without excessive stress. Exercise also has well-documented anti-inflammatory effects independent of hormonal status.

Dietary support
Anti-inflammatory dietary patterns (Mediterranean-style, high in omega-3 fatty acids, vegetables, and polyphenols) are associated with lower levels of systemic inflammation. Foods rich in collagen precursors (vitamin C, glycine from bone broth) may support connective tissue, though evidence is modest.

Supplements
Omega-3 fatty acids (EPA and DHA) have demonstrated anti-inflammatory effects in joint tissue in multiple RCTs. Glucosamine and chondroitin have mixed evidence but are widely used. Vitamin D deficiency — common in women post-menopause — is independently associated with musculoskeletal pain and should be assessed.

The Importance of Not Dismissing the Symptom

Here is the clinical concern that underpins this article: joint pain in midlife women is frequently undertreated because it is attributed to ageing alone. This framing has consequences.

First, it removes the possibility of hormonal management that may genuinely help. Second, it delays investigation into conditions like inflammatory arthritis or accelerating osteoarthritis that benefit from early intervention. Third, it leaves women managing pain with over-the-counter anti-inflammatories long-term — which carry their own gastrointestinal and cardiovascular risks with extended use.

If you are a woman in your forties or fifties experiencing new or worsening joint pain, you deserve a thorough clinical evaluation that includes hormonal status.

Frequently Asked Questions

Does menopause cause joint pain?
Yes. Falling oestrogen levels during perimenopause and menopause are directly linked to increased joint pain and stiffness. Oestrogen supports cartilage health, regulates inflammation, and influences pain perception. When it declines, joints can become more painful — independently of ageing.

Where does menopause joint pain occur most?
The most commonly affected joints are the hands and fingers, knees, hips, and lower back. Pain is often bilateral (both sides of the body) and may be accompanied by morning stiffness that improves with movement.

Can HRT help with joint pain?
Research suggests oestrogen-containing HRT is associated with reduced joint pain and may slow osteoarthritis progression in certain joints. HRT is a prescription treatment and requires individual assessment by a healthcare professional.

When does joint pain start in perimenopause?
Joint pain can begin in perimenopause — the transition phase that may start in the early-to-mid forties — even before periods become irregular. Hormonal fluctuations during this time are associated with increased musculoskeletal symptoms.

Is menopause joint pain the same as arthritis?
Not necessarily, though menopause can increase the risk of developing osteoarthritis. Menopausal joint pain is hormonally driven and may improve with hormonal management. A clinical assessment can help distinguish between the two.

References

1. Barnabei VM et al. "Menopausal symptoms in older women and the effects of treatment with hormone therapy." Menopause. 2002;9(1):19–28.
2. Szoeke CE et al. "The relationship between prospectively assessed hot flushes and estradiol levels in the early years of the menopause transition." Maturitas. 2008;59(3):205–212.
3. Straub RH. "The complex role of estrogens in inflammation." Endocrine Reviews. 2007;28(5):521–574.
4. Roman-Blas JA et al. "Osteoarthritis associated with estrogen deficiency." Arthritis Research & Therapy. 2009;11(5):241.
5. Massafra C et al. "Effects of estrogens and androgens on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels." Clinical Endocrinology. 1999;51(4):467–473. [Collagen synthesis data cross-referenced with Stevenson JC. QJM. 2003.]
6. Craft RM. "Modulation of pain by estrogens." Pain. 2007;132(Suppl 1):S3–S12.
7. Wluka AE et al. "Menopausal status and the effects of hormone therapy on cartilage and bone in osteoarthritis of the knee: a systematic review." Osteoarthritis and Cartilage. 2000;8(1):75–81.
8. Cirillo DJ et al. "Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative." Arthritis & Rheumatism. 2006;54(10):3194–3204.

About Zoey

Zoey is a menopause wellness brand built for women in Asia who want evidence-based support through perimenopause, menopause, and beyond. Our content is medically reviewed and written to the same standard we'd want for ourselves.

Experiencing joint pain and wondering if hormones are involved?
Take Zoey's menopause symptom assessment at zoey.sg — built for Singapore women, with real clinical guidance.